FDA Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of FDA Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Cancer Vaccines

Dynavax Provides 2007 Financial Outlook

The following statements are forward-looking and are based on current expectations. Actual results may differ materially. Except as expressly set forth below, these statements do not include the potential impact of any equity offerings, new business collaborations or other transactions that may be closed or entered into after February 23, 2007.

The company's consolidated cash, cash equivalents, marketable securities and investments held by Symphony Dynamo, Inc. (SDI), or total cash, were $86 million at the beginning of 2007. Total cash will increase by $30...

• View Other Issues of FDA Law Weekly
  
• View Other NewsRx Publications